Reuters logo
BRIEF-Rexahn Pharmaceuticals reports Q1 loss per share $0.09
2017年5月4日 / 下午1点26分 / 7 个月前

BRIEF-Rexahn Pharmaceuticals reports Q1 loss per share $0.09

May 4 (Reuters) - Rexahn Pharmaceuticals Inc:

* Rexahn Pharmaceuticals reports first quarter 2017 financial results and provides corporate update

* Q1 loss per share $0.09

* Q1 earnings per share view $-0.02 -- Thomson Reuters I/B/E/S

* Rexahn Pharmaceuticals - expects its current cash and investments will be sufficient to fund cash flow requirements for current activities into mid-2018 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below